Some peptides are investigational/off-label and not FDA-approved for veterinary use
Compared with placebo, both tirzepatide (HR 0.78, 95% CI 0.660.93) and the GLP-1RA class (HR 0.85, 95% CI 0.800.91) were associated with lower risk of MACE, with moderate heterogeneity (Q = 13.9 [ p = 0.126], 2 = 0.0040, I 2 = 35.26%)
Treatment with GLP-1 during the proestrus phase in rats doubled the LH serum level and resulted in exerting progesterone in the luteal phase, constantly increasing the number of mature Graafian follicles, resulting in increased fertility [110]
Specifically, those taking GLP-1 Shot lost an average of 16% of their initial body weight, while individuals taking Liraglutide lost an average of 6%.* Here is a look at some of the impressive weight loss before and after results from people using GLP-1 Shot injections
When discomfort becomes a red flag Call your clinician if you have severe abdominal pain, repeated vomiting, inability to keep fluids down, fainting, signs of dehydration, black stools, or symptoms that keep worsening
This article examines the evidence, explores safer alternatives such as metformin and insulin, and provides guidance on when to consult your GP about diabetes management during breastfeeding
